For IPO Boutique's "scale of 1 to 5" BUY rating on Editas Medicine, and our comprehensive analysis, click "Buy Market Research".
Editas Medicine Quote & Chart - Click for current quote - EDIT
About Editas Medicine (adapted from Editas Medicine prospectus): Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "EDIT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
